## Gland Pharma gets US FDA nod for Edaravone Injection! 💉 #PharmaNews #FDAApproval The generic drugmaker expects to launch the ALS treatment via its partner within FY25. The product boasts a US market size of ~$19M. #stocks #stockmarkets

APAC leads in #asthma #clinicaltrials between 2019-2023: #GlobalData - bit.ly/3QA7VnR | #pharma #pharmanews #healthtech #parmatech #medtech

Indian #Pharma Urges US-India partnership for affordable #Medicine - bit.ly/3Wwre57 | #Pharmanews #healthtech #parmatech #medtech

Check out this week's episode of Off Script: A Pharma Manufacturing Podcast where we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. pharmamanu.podbean.com/e/neurocrine-w… #pharmamanufacturing #offscript #pharmanews #podcast

NRx Pharmaceuticals today announced a statistically significant safety advantage of NRX-101 compared to the standard of care comparator in its recently completed clinical trial in patients with suicidal bipolar depression. Read More - ir.nrxpharma.com/2024-05-06-NRx… #PharmaNews $NRXP

Sharp spike in #pharma, #healthcare #funding in April 2024, touches $332 mn - bit.ly/3y8kMY4 | #pharmanews #healthtech #parmatech #medtech #fintech

Maryland-based GlycoMimetics revealed this week that the phase 3 trial for its relapsed/refractory acute myeloid leukemia drug, uproleselan, had not met its primary endpoint of overall survival. #GlycoMimetics #Leukemia #pharmamanufacturing #pharmanews pharmamanufacturing.com/development/cl…

This week, the 2024 edition of CPHI North America is expected to draw thousands of pharma professionals from over 101 countries. Learn about the event where the U.S. pharma market gathers. ➡️ hubs.li/Q02w85WX0 #pharma #CPHI #pharmanews

$NRXP $2.27 +8.10% Premarket- New analyst report from Ed Woo, CFA, NRx Pharmaceuticals publishing analyst at Ascendiant Capital Markets. View Report: nrxpharma.com/wp-content/up #PharmaNews #mentalillness #depression #ketamine #stress #PTSD #suicide #bipolar #NRX101 $NRXP #Bullish

New analyst report from Ed Woo, CFA, NRx Pharmaceuticals publishing analyst at Ascendiant Capital Markets. View Report - nrxpharma.com/wp-content/upl… #PharmaNews #mentalillness #depression #ketamine #stress #PTSD #suicide #bipolar #NRX101 $NRXP

#pharmaP2024 held in #Amsterdam, marks its fourth edition - bit.ly/3UOgyxq | #pharma #pharmanews #healthtech #parmatech #medtech

Research led by #Sydney University develop #nanotech-based oral #insulin #medicine - bit.ly/3wlzISa | #pharma #pharmanews #healthtech #parmatech #medtech

Lupin gets US FDA nod for generic Travoprost Ophthalmic Solution! 🎉 This move allows Lupin to tap into the $77 million US market for the drug, boosting its presence in the ophthalmic segment. #Lupin #PharmaNews #EyeCare #stocks #stockmarkets

Chinese companies lead ADC development pipeline: #GlobalData - bit.ly/3JUBEUB | #pharma #pharmanews #healthtech #parmatech #medtech

Is your work revolutionising healthcare? 🩺Share your groundbreaking achievements and gain industry recognition. Seek guidance with an award winning submission today! Download now for inspiration. More: landing.businessriver.com/Pharma-Industr… #PharmaIndustry #PharmaNews #PharmaUK

Results show potential of J&J’s TAR-210 to transform treatment of bladder #cancer with #FGFR alterations - bit.ly/3wqFdPp | #pharma #pharmanews #healthtech #parmatech #medtech

Caplin Point Labs receives Colombia INVIMA approval for its Softgel Capsules division, expanding its reach in Latin America. #PharmaNews #LatinAmerica #Growth #stocks #stockmarkets

## Alembic Pharma gets US FDA all-clear for its Panelav Oncology facility! This comes after a successful inspection in Feb-March 2024. #PharmaNews #FDAApproval #AlembicPharma $APLLTD #stocks #stockmarkets

MedPlus Health subsidiary Optival Health receives temporary suspension orders for 3 stores in Andhra Pradesh and Karnataka for 7 days each. Potential revenue loss estimated at Rs 5.48 lakhs. #MedPlusHealth #PharmaNews #RegulatoryAction #stocks #stockmarkets